Clinical Trials
49 trialsMultiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse
Exelixis
cCeLLExvivo
VPIX Medical
A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement
Pfizer
Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
Novartis
STAR-3
Kintara Therapeutics, Inc.
PEAR-GLIO
Ourotech, Inc.
RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases
Biogen
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
Blueprint Medicines Corporation
Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
Lumicell, Inc.
KONQUER
Bexion Pharmaceuticals, Inc.
Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.
ABM Therapeutics Corporation
PIRATE
EpicentRx, Inc.
Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Basilea Pharmaceutica
Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors
Pyramid Biosciences
Discerning Pseudoprogression vs True Tumor Growth in GBMs
Ascension Health
Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Y-mAbs Therapeutics
ALpha-T
Hoffmann-La Roche
POLARIS
Pfizer
KING
Karyopharm Therapeutics Inc
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
Boston Scientific Corporation
E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS)
Spirita Oncology, LLC
Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer
Kadmon Corporation, LLC
Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)
Proximagen, LLC
KOURAGE
Bexion Pharmaceuticals, Inc.
A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
Tocagen Inc.
A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
Daiichi Sankyo
A Secondary Study Evaluating Aqueduct's Smart External Drain (SED)
Aqueduct Critical Care
GRABM-L
Angiochem Inc
Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites
GlaxoSmithKline
Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas
Arog Pharmaceuticals, Inc.
Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma
Novartis
STOP
Merck Sharp & Dohme LLC
Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)
Merck Sharp & Dohme LLC
Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
Novartis
PET Imaging of Intracranial Cancers With 18F-FSPG
Lantheus Biosciences Ltd.
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
Novartis
Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
NovoCure Ltd.
Brain Metastases In ErbB2-Positive Breast Cancer
GlaxoSmithKline
SAPPHIRE
Isarna Therapeutics GmbH
Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases
Pharmacyclics LLC.
Tolerability Study of Xerecept® in Pediatric Patients
Celtic Pharma Development Services
18F ML-10 for Early Detection of Response of Brain Metastases to SRS
Aposense Ltd.
A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases
YM BioSciences
Navigated Transcranial Magnetic Stimulation in Tumor Surgery
Nexstim Ltd
Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma
Diffusion Pharmaceuticals Inc
Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
Thallion Pharmaceuticals
Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer
AstraZeneca
Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)
PharmaNet
Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
Boneca Corporation